Literature DB >> 23426493

Intralesional immunotherapy with Mycobacterium w vaccine in patients with multiple cutaneous warts: uncontrolled open study.

Jitendra K Meena, Amit K Malhotra, Deepak K Mathur, Dinesh C Mathur.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23426493     DOI： 10.1001/jamadermatol.2013.866

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  8 in total

1.  An Intention-to-Treat-Analysis of the Efficacy of Immunotherapy Using Mycobacterium W Vaccine and Purified Protein Derivative of Tuberculin for Warts With Assessment of Improvement in Quality of Life.

Authors:  Alpana Mohta; Manoj Kumar Sharma; Pramila Kumari; Bhikam Chand Ghiya; Rajesh Dutt Mehta
Journal:  Dermatol Pract Concept       Date:  2022-04-01

2.  Intralesional Purified Protein Derivative of Tuberculin Versus Intralesional Mycobacterium W Vaccine in Treatment of Recalcitrant Extragenital Warts: A Randomized, Single-Blinded, Comparative Study.

Authors:  Alpana Mohta; Suresh Kumar Jain; Rajesh Dutt Mehta; Aakanksha Arora
Journal:  Indian J Dermatol       Date:  2022 Jan-Feb       Impact factor: 1.757

Review 3.  Immunomodulators in warts: Unexplored or ineffective?

Authors:  Surabhi Sinha; Vineet Relhan; Vijay K Garg
Journal:  Indian J Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.494

4.  Intralesional immunotherapy for difficult to treat warts with Mycobacterium w vaccine.

Authors:  Shilpa Garg; Sukriti Baveja
Journal:  J Cutan Aesthet Surg       Date:  2014 Oct-Dec

Review 5.  Evolving role of immunotherapy in the treatment of refractory warts.

Authors:  Devinder M Thappa; Minu J Chiramel
Journal:  Indian Dermatol Online J       Date:  2016 Sep-Oct

6.  Bacillus Calmette-Guerin Immunotherapy for Recurrent Multiple Warts: An Open-Label Uncontrolled Study.

Authors:  Avtar Kishan Jaisinghani; Vivek Kumar Dey; M S Suresh; Animesh Saxena
Journal:  Indian J Dermatol       Date:  2019 Mar-Apr       Impact factor: 1.494

7.  Changes in Cytokine Profile with Immunotherapy in Viral Warts using Purified Protein Derivative, Mumps Measles Rubella Vaccine, and Mycobacterium w Vaccine.

Authors:  Amrita Sil; Sayantan Dasgupta; Somodyuti Chandra; Adrija Datta; Arini Banerjee; Nilay Kanti Das
Journal:  Indian J Dermatol       Date:  2021 Jan-Feb       Impact factor: 1.494

8.  A Randomized Comparative Study of MIP and MMR Vaccine for the Treatment of Cutaneous Warts.

Authors:  Amandeep Kaur; Balvinder Kaur Brar; Sumir Kumar; Sukhmani Kaur Brar; Amarbir Singh Boparai; Neerja Puri
Journal:  Indian J Dermatol       Date:  2021 Mar-Apr       Impact factor: 1.494
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.